Shares of medical technology company Inspire Medical Systems (NYSE:INSP) fell 41.3% in the afternoon session after the ...

Inspire Medical Systems (NYSE:INSP) saw its stock plunge 27% following disappointing quarterly results and a lowered outlook, which led four major Wall Street firms to downgrade the shares. Truist ...

Inspire Medical Systems, Inc. (NYSE:INSP) is one of the top oversold NYSE stocks to buy now. Robert W. Baird analyst David ...

Inspire Medical stock falls as Q2 earnings beat is overshadowed by guidance cut and slower U.S. rollout of its newly approved ...

Q2 2025 Earnings Call Transcript August 4, 2025 Inspire Medical Systems, Inc. beats earnings expectations. Reported EPS is $0 ...

Inspire and other medical-technology firms saw their stock prices decline on concerns that the growing use of GLP-1 weight-loss drugs would reduce the need for treatments of obesity-related ...

Investing.com -- Inspire Medical Systems (NYSE: INSP) stock plunged 27% after the company’s disappointing quarterly results and guidance prompted four Wall Street firms to downgrade the shares.

Inspire Medical Systems (INSP) stock drops despite strong Q2 2025 results as it cuts 2025 forecasts amid headwinds to Inspire ...

Three new studies suggest that Ozempic and related diabetes and weight loss drugs may help protect the brain from strokes.

Hormones play a significant role in weight management, influencing appetite, metabolism, and fat storage. Silvia went to Inspire Medical to learn more about what we can do to have our hormones working ...

One-month return of Inspire Medical Systems, Inc. (NYSE:INSP) was 39.29%, and its shares lost 20.27% of their value over the last 52 weeks. Inspire Medical Systems, Inc. (NYSE:INSP) has a market ...